A Study to Compare Two Methods for Following Patients with Pancreatic Cysts

Overview

Información sobre este estudio

The purpose of this study is to compare the two approaches for monitoring pancreatic cysts - more frequent monitoring vs. less frequent monitoring in order to learn which monitoring method leads to better outcome for patients with pancreatic cysts.

Elegibilidad para la participación

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

Inclusion Criteria:

  • Between 50 and 75 years of age, inclusive.
  • Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status 0-1.
  • Patient must not have acute pancreatitis or a history of chronic pancreatitis.
  • Patient must have received a computed tomography (CT) or magnetic resonance imaging (MRI) within 3 months of registration that revealed a newly identified ≥ 1 cm pancreatic cyst.
  • Women of childbearing potential must not be known to be pregnant.
  • Patient must not have a prior diagnosis of pancreatic cyst or pancreatic malignancy of any type.
  • Patient must not have a history of pancreatic resection.
  • Patient must not have other asymptomatic pancreatic cystic lesion with zero/low malignancy potential (pancreatic pseudocyst, classic serous cystic lesion) on index CT or MRI.
  • Patient must not have a family history of pancreatic adenocarcinoma in 1 or more first degree relatives.
  • Patient must not have pancreatic cyst morphology that would prompt immediate surgical consideration (enhancing mural nodule, solid component in cyst, pancreatic duct > 10 mm, cyst causing obstructive jaundice).
  • Patient must not have a comorbid illness that precludes pancreatic cyst resection.
  • Patient must not be participating in an already established surveillance program.

Exclusion Criteria:

  • Under 50 or over 75 years of age.

Sedes participantes de Mayo Clinic

Los estatus de los estudios cambian con frecuencia. Comunícate con el equipo del estudio para obtener la información más actualizada acerca de la posibilidad de participar.

Sede de Mayo Clinic Estatus Contacto

Rochester, Minn.

Investigador principal de Mayo Clinic

Shounak Majumder, M.D.

Comunícate con nosotros para obtener el estatus más reciente

Contact information:

Cancer Center Clinical Trials Referral Office

855-776-0015

Jacksonville, Fla.

Investigador principal de Mayo Clinic

Yan Bi, M.D., Ph.D.

Comunícate con nosotros para obtener el estatus más reciente

Contact information:

Cancer Center Clinical Trials Referral Office

855-776-0015

Scottsdale/Phoenix, Ariz.

Investigador principal de Mayo Clinic

Rahul Pannala, M.D.

Comunícate con nosotros para obtener el estatus más reciente

Contact information:

Cancer Center Clinical Trials Referral Office

(855) 776-0015

More information

Publicaciones

Publications are currently not available
.
CLS-20506534

Mayo Clinic Footer